{"id":482238,"date":"2024-01-04T18:00:18","date_gmt":"2024-01-05T02:00:18","guid":{"rendered":"https:\/\/nai500.com\/blog\/2024\/01\/%e5%88%86%e6%9e%90%e5%b8%88-%e7%9c%8b%e6%b6%a8-%e6%9c%a8%e5%a4%b4%e5%a7%90%e8%82%a1%e7%a5%a8-%e5%8c%bb%e7%96%97%e8%a1%8c%e4%b8%9a\/"},"modified":"2024-01-04T18:00:37","modified_gmt":"2024-01-05T02:00:37","slug":"%e5%88%86%e6%9e%90%e5%b8%ab-%e7%9c%8b%e6%bc%b2-%e6%9c%a8%e9%a0%ad%e5%a7%90%e8%82%a1%e7%a5%a8-%e9%86%ab%e7%99%82%e8%a1%8c%e6%a5%ad","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2024\/01\/%e5%88%86%e6%9e%90%e5%b8%ab-%e7%9c%8b%e6%bc%b2-%e6%9c%a8%e9%a0%ad%e5%a7%90%e8%82%a1%e7%a5%a8-%e9%86%ab%e7%99%82%e8%a1%8c%e6%a5%ad\/","title":{"rendered":"\u5206\u6790\u5e2b\u4e00\u81f4\u770b\u6f32\u90198\u53ea\u6728\u982d\u59d0\u80a1\u7968\uff0c\u5176\u4e2d5\u53ea\u4f86\u81ea\u91ab\u7642\u884c\u696d"},"content":{"rendered":"

\u6728\u982d\u59d0\u7684\u57fa\u91d1ARK Innovation ETF\uff08ARKK\uff09\u5f9e\u4f86\u4e0d\u61fc\u8ddf\u83ef\u723e\u8857\u548c\u6a19\u666e500\u6307\u6578\u5531\u53cd\u8abf\uff0c\u4f46\u6709\u4e9b\u6642\u5019\uff0c\u9019\u4f4d\u79d1\u6280\u6295\u8cc7\u4e00\u59d0\u8ddf\u5206\u6790\u5e2b\u4e5f\u80fd\u9054\u6210\u4e00\u81f4\u610f\u898b\u3002<\/p>\n

\u5c31\u6bd4\u5982\u8aaa\uff0c\u5206\u6790\u5e2b\u8a8d\u70baARK Innovation\u76848\u53ea\u80a1\u7968\uff0c\u5305\u62ecVerve Therapeutics Inc\uff08NASDAQ:VERV\uff09<\/a>\u30012U Inc\uff08NASDAQ:TWOU\uff09\u548cIntellia Therapeutics Inc\uff08NASDAQ:NTLA\uff09\u7684\u80a1\u50f9\u5c07\u5728\u672a\u4f8612\u500b\u6708\u4e0a\u6f3250%\u53ca\u4ee5\u4e0a\u3002<\/p>\n

\u76f8\u6bd4\u4e4b\u4e0b\uff0c\u5373\u4f7f\u662f\u83ef\u723e\u8857\u6700\u6a02\u89c0\u7684\u5206\u6790\u5e2b\uff0c\u4e5f\u53ea\u6562\u9810\u6e2c\u4eca\u5e74\u6a19\u666e500\u6307\u6578\u5c07\u4e0a\u6f32\u7d049%\u3002\u5206\u6790\u5e2b\u5982\u6b64\u770b\u597d\u9019\u4e9b\u6728\u982d\u59d0\u80a1\u7968\uff0c\u5176\u4e2d\u591a\u6578\u90fd\u4f86\u81ea\u65bc\u91ab\u7642\u677f\u584a\uff0c\u9019\u7576\u4e2d\u9084\u662f\u900f\u9732\u51fa\u4e86\u4e00\u4e9b\u6709\u50f9\u503c\u7684\u4fe1\u606f\u3002<\/p>\n

\u6728\u982d\u59d0\u7684\u6295\u8cc7\u98a8\u683c<\/h2>\n

\u6295\u8cc7\u8005\u5982\u6b64\u57f7\u8457\u4e8e\u6728\u982d\u59d0\u7684ARK Innovation\uff0c\u9019\u5176\u5be6\u4e0d\u96e3\u7406\u89e3\uff0c\u9019\u5b8c\u5168\u53d6\u6c7a\u65bc\u5979\u7684\u6295\u8cc7\u98a8\u683c\u3002\u5728\u5e02\u5834\u884c\u60c5\u597d\u7684\u6642\u5019\uff0c\u9019\u53ea\u57fa\u91d1\u7e3d\u80fd\u4e00\u98db\u6c96\u5929\u3002<\/p>\n

\u5c31\u62ff2023\u5e74\u4f86\u8aaa\u3002\u8a72ETF\u53bb\u5e74\u7684\u7e3d\u6536\u76ca\u7387\u70ba67.64%\uff0c\u662f\u7f8e\u570b\u8868\u73fe\u6700\u597d\u7684\u4e3b\u52d5\u7ba1\u7406\u578b\u591a\u5143\u5316ETF\uff0c\u751a\u81f3\u8dd1\u8d0f\u4e86Invesco Nasdaq 100 ETF\uff08QQQM\uff09\u768455.0%\uff0c\u540c\u671fSPDR S&P 500 ETF Trust\uff08NYSE:SPY\uff09\u7684\u6536\u76ca\u7387\u53ea\u670926.2%\u3002\u5982\u679c2024\u5e74\u6a19\u666e500\u6307\u6578\u518d\u5ea6\u8d70\u5f37\uff0c\u6728\u982d\u59d0\u504f\u611b\u7684\u9019\u985e\u9ad8\u7206\u767c\u529b\uff0c\u80a1\u50f9\u5f48\u6027\u6975\u5927\u7684\u80a1\u7968\u81ea\u7136\u6703\u5438\u5f15\u6240\u6709\u4eba\u7684\u95dc\u6ce8\u3002<\/p>\n

\u7e3d\u7684\u4f86\u770b\uff0cARK Innovation\u768434\u53ea\u6301\u80a1\u7576\u4e2d\uff0c\u591a\u6578\u500b\u80a1\u90fd\u88ab\u5206\u6790\u5e2b\u770b\u597d\u3002\u4ed6\u5011\u8a8d\u70ba\u9019\u4e9b\u80a1\u7968\u7684\u50f9\u683c\u672a\u4f8612\u500b\u6708\u5c07\u5e73\u5747\u4e0a\u6f32\u8fd130%\uff0c<\/p>\n

\u91ab\u7642\u80a1\u5360\u534a\u58c1\u6c5f\u5c71<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n
\u516c\u53f8<\/strong><\/td>\n\u80a1\u7968\u4ee3\u78bc<\/strong><\/td>\n\u80a1\u50f9\u4e0a\u6f32\u7a7a\u9593<\/strong><\/td>\n\u677f\u584a<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Verve Therapeutics<\/td>\n(VERV)<\/td>\n229.2%<\/td>\n\u91ab\u7642<\/td>\n<\/tr>\n
2U<\/td>\n(TWOU)<\/td>\n178.0%<\/td>\n\u53ef\u9078\u6d88\u8cbb<\/td>\n<\/tr>\n
Intellia Therapeutics<\/td>\n(NTLA)<\/td>\n150.4%<\/td>\n\u91ab\u7642<\/td>\n<\/tr>\n
Invitae<\/td>\n(NVTA)<\/td>\n109.0%<\/td>\n\u91ab\u7642<\/td>\n<\/tr>\n
Ginkgo Bioworks Holdings<\/td>\n(DNA)<\/td>\n103.6%<\/td>\n\u6750\u6599<\/td>\n<\/tr>\n
Cerus<\/td>\n(CERS)<\/td>\n91.0%<\/td>\n\u91ab\u7642<\/td>\n<\/tr>\n
Beam Therapeutics<\/td>\n(BEAM)<\/td>\n74.9%<\/td>\n\u91ab\u7642<\/td>\n<\/tr>\n
Archer Aviation<\/td>\n(ACHR)<\/td>\n52.4%<\/td>\n\u5de5\u696d<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u5728\u83ef\u723e\u8857\u770b\u597d\u7684\u6728\u982d\u59d0\u80a1\u7968\u7576\u4e2d\uff0c5\u53ea\u90fd\u4f86\u81ea\u65bc\u91ab\u7642\u677f\u584a\u4e14\u6295\u6a5f\u6027\u660e\u986f\uff0c\u5176\u4e2d\u6700\u770b\u597d\u7684\u57fa\u56e0\u7de8\u8f2f\u516c\u53f8Verve Therapeutics\u5360ARK Innovation\u7684\u6b0a\u91cd\u50c5\u67090.5%\u3002\u5206\u6790\u5e2b\u9810\u8a08\u8a72\u80a1\u80a1\u50f9\u672a\u4f8612\u500b\u6708\u5c07\u4e0a\u6f32229%\u81f345.89\u7f8e\u5143\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0cVerve\u80a1\u50f92023\u5e74\u4e0b\u8dcc28%\uff0c\u53bb\u5e74\u6bcf\u80a1\u8667\u640d3.26\u7f8e\u5143\uff0c\u4e26\u4e14\u5206\u6790\u5e2b\u9810\u8a08\u8a72\u516c\u53f8\u81f3\u5c11\u52302027\u5e74\u4e4b\u524d\u90fd\u7121\u6cd5\u76c8\u5229\u3002<\/p>\n

\u53e6\u4e00\u96bb\u88ab\u5206\u6790\u5e2b\u770b\u597d\u7684\u6728\u982d\u59d0\u80a1\u7968\u4e5f\u662f\u4e00\u5bb6\u57fa\u56e0\u7de8\u8f2f\u80a1\u7968Intellia Therapeutics\uff0c\u5206\u6790\u5e2b\u9810\u8a08\u8a72\u80a1\u80a1\u50f9\u4eca\u5e74\u5c07\u4e0a\u6f32\u8d85\u904e150%\u3002\u8a72\u80a1\u5360ARK Innovation\u7684\u6b0a\u91cd\u70ba2.8%\uff0c\u7a0d\u9ad8\u65bcVerve\u4f46\u6bd4\u91cd\u4e5f\u4e0d\u9ad8\uff0c\u540c\u6642\u8a72\u516c\u53f82023\u5e74\u6bcf\u80a1\u8667\u640d5.38\u7f8e\u5143\uff0c\u4e26\u4e14\u8667\u640d\u72c0\u614b\u5c07\u6301\u7e8c\u81f32027\u5e74\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u6728\u982d\u59d0\u7684\u57fa\u91d1ARK Innovation ETF\uff08ARKK\uff09\u5f9e\u4f86\u4e0d\u61fc\u8ddf\u83ef\u723e\u8857\u548c\u6a19\u666e500\u6307\u6578\u5531\u53cd\u8abf\uff0c\u4f46\u6709\u4e9b\u6642\u5019 […]<\/p>\n","protected":false},"author":27,"featured_media":403001,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[809,2156,2227,927],"class_list":["post-482238","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-809","tag-2156","tag-2227","tag-927","sectors--zh-hant","sectors-life-science-zh-hant","sectors-technology-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/482238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=482238"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/482238\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/403001"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=482238"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=482238"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=482238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}